Follow Us
https://www.thebody.com/category/hiv-trump/tag/news-analysis

The Latest

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next? Img

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?

Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

The Trump Administration's Drug Pricing Proposals for People With HIV, Explained Img

The Trump Administration's Drug Pricing Proposals for People With HIV, Explained

Drug pricing expert Tim Horn helps us make sense of the administration's future plans for the Medicare Part D and 340B programs.

A Supreme Court Justice Brett Kavanaugh Could Be Disastrous for People Living With HIV, but He's Not The Worst Case Scenario Img

A Supreme Court Justice Brett Kavanaugh Could Be Disastrous for People Living With HIV, but He's Not The Worst Case Scenario

"While Kavanaugh's appointment to the Supreme Court might not spell the end of the Affordable Care Act it could certainly lead to the chipping away at protections for millions of Americans who benefit from it."

'Trouble Ahead?' and American flag

With Government Restructuring Plan, Trump Administration Takes Aim at Programs Used by People Living With HIV

The Trump administration is planning a radical reorganization of the federal government that could adversely impact people living with HIV.

2018 Budget

Stay Vigilant: President Trump's Budget Is Just One Threat to Global HIV/AIDS Funds

President Trump's budget is viewed as "dead on arrival" by members of Congress, notes Drew Gibson. But don't be fooled, he says: Killer HIV funding threats are not going away -- and here's what you need to do about it.

Trump Sends Chilling Proposal to Congress With Deadly Proposition: Cap HIV Treatment Expansion Immediately Img

Trump Sends Chilling Proposal to Congress With Deadly Proposition: Cap HIV Treatment Expansion Immediately

Trump wants to slash funding for the wildly successful and bipartisan-backed President's Emergency Plan for AIDS Relief (PEPFAR) by $300 million and "begin slowing the rate of new patients on treatment in FY 17."